Literature DB >> 32489919

Optical coherent tomography to evaluate the degree of inflammation in a mouse model of colitis.

Jian Ding1, Jiewen Lin2, Qiu Li1, Xiaoping Chen3, Weiqiang Chen2, Qiukun Zhang2, Shanshan He1, Ting Wu1, Chengdang Wang1, Shuncong Zhong2, Dan Li4.   

Abstract

BACKGROUND: There is an urgent need to develop a noninvasive imaging technique for the diagnosis of early inflammatory lesions or early and real-time microscopic assessment before selecting the most representative biopsy sites.
METHODS: In this study, a dextran sulfate sodium colitis model was developed, and intestinal histological damage scores measured the degree of inflammation in colitis. According to these scores, 6 parameters were designed for hematoxylin and eosin (HE) sections based on morphological changes, and 2 parameters were designed for optical coherence tomography (OCT) images to measure submucosal edema by morphological changes to evaluate inflammation degrees in the colon. Spearman's rank correlation method was used to compare the correlation between the submucosal morphological changes and the different degrees of inflammation. One-way analysis of variance (ANOVA) was used for comparisons among groups, while receiver operating characteristic (ROC) curves of the indicators in HE sections and OCT images were plotted.
RESULTS: In HE sections, angle of mucosal folds (r=0.853, P<0.01), length of basilar parts (r=0.915, P<0.01), submucosal area (r=0.819, P<0.01), and height between submucosal and muscular layers (r=0.451, P=0.001) were correlated with the degree of inflammation in colitis. In OCT images, length of basilar parts (r=0.800, P<0.01) and height of submucosa + thickness of muscularis (r=0.648, P=0.001) were correlated with the degree of inflammation and aided the measurement of inflammation in the colon.
CONCLUSIONS: Parameters based on morphological changes in OCT images and HE sections were significant indexes for evaluating the degree of inflammation in colitis. OCT images have advantages for future clinical applications in situ, including noninvasiveness and real-time imaging. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Tomography, optical coherence; colitis; hematoxylin-eosin staining (HE staining); inflammation; inflammatory bowel disease

Year:  2020        PMID: 32489919      PMCID: PMC7242297          DOI: 10.21037/qims.2020.04.04

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  24 in total

Review 1.  Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy.

Authors:  J G Fujimoto; C Pitris; S A Boppart; M E Brezinski
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 2.  Optical coherence tomography for ultrahigh resolution in vivo imaging.

Authors:  James G Fujimoto
Journal:  Nat Biotechnol       Date:  2003-11       Impact factor: 54.908

3.  Optical biopsy in human gastrointestinal tissue using optical coherence tomography.

Authors:  G J Tearney; M E Brezinski; J F Southern; B E Bouma; S A Boppart; J G Fujimoto
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

4.  Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis.

Authors:  Bart Lemmens; Ingrid Arijs; Gert Van Assche; Xavier Sagaert; Karel Geboes; Marc Ferrante; Paul Rutgeerts; Séverine Vermeire; Gert De Hertogh
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

Review 5.  An Update on Inflammatory Bowel Disease.

Authors:  Tomoko Sairenji; Kimberly L Collins; David V Evans
Journal:  Prim Care       Date:  2017-10-05       Impact factor: 2.907

Review 6.  MR Enterography of Inflammatory Bowel Disease with Endoscopic Correlation.

Authors:  Pankaj Kaushal; Alexander S Somwaru; Aline Charabaty; Angela D Levy
Journal:  Radiographics       Date:  2016-11-25       Impact factor: 5.333

Review 7.  The meaning of low-grade inflammation in clinically quiescent inflammatory bowel disease.

Authors:  Alan C Moss
Journal:  Curr Opin Gastroenterol       Date:  2014-07       Impact factor: 3.287

Review 8.  Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.

Authors:  Mayumi Kawada; Atsuko Arihiro; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

Review 9.  Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system.

Authors:  Pier-Alberto Testoni; Benedetto Mangiavillano
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

Review 10.  Origin and physiological roles of inflammation.

Authors:  Ruslan Medzhitov
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

View more
  4 in total

1.  Differential diagnosis of acute and chronic colitis in mice by optical coherence tomography.

Authors:  Dan Li; Shijie Ding; Manting Luo; Jinguo Chen; Qiukun Zhang; Yijuan Liu; Anlan Li; Shuncong Zhong; Jian Ding
Journal:  Quant Imaging Med Surg       Date:  2022-06

2.  Animal Models and Pathogenesis of Ulcerative Colitis.

Authors:  Xin Gao; Jia Li; Xueping Pang; Kaiyuan Cong; Chunlei Jiang; Bingxuan Han; Jiawei Gao; Zhihao Wang; Jiangshan Hu; Kaijun Wen; Xinfa Ye; Liwen Dou
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

3.  Optical coherence tomography for the early detection of colorectal dysplasia and cancer: validation in a murine model.

Authors:  Jian Ding; Qiu Li; Jiewen Lin; Shanshan He; Weiqiang Chen; Qiyong He; Qiukun Zhang; Jintong Chen; Ting Wu; Shuncong Zhong; Dan Li
Journal:  Quant Imaging Med Surg       Date:  2021-01

4.  Soy diet induces intestinal inflammation in adult Zebrafish: Role of OTX and P53 family.

Authors:  Giovanni Micheloni; Marta Carnovali; Giorgia Millefanti; Manuel Rizzetto; Vittoria Moretti; Giuseppe Montalbano; Francesco Acquati; Cristina Giaroni; Roberto Valli; Lucy Costantino; Fulvio Ferrara; Giuseppe Banfi; Massimo Mariotti; Giovanni Porta
Journal:  Int J Exp Pathol       Date:  2021-11-01       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.